0001415889-23-011175.txt : 20230717
0001415889-23-011175.hdr.sgml : 20230717
20230717180251
ACCESSION NUMBER: 0001415889-23-011175
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230711
FILED AS OF DATE: 20230717
DATE AS OF CHANGE: 20230717
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moss Dana J
CENTRAL INDEX KEY: 0001985665
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35076
FILM NUMBER: 231092545
MAIL ADDRESS:
STREET 1: 4995 BRADENTON AVE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000810509
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 311080091
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4995 BRADENTON AVENUE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
BUSINESS PHONE: 6147937500
MAIL ADDRESS:
STREET 1: 4995 BRADENTON AVENUE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
FORMER COMPANY:
FORMER CONFORMED NAME: NEOPROBE CORP
DATE OF NAME CHANGE: 19940714
4
1
form4-07172023_100748.xml
X0508
4
2023-07-11
0000810509
NAVIDEA BIOPHARMACEUTICALS, INC.
NAVB
0001985665
Moss Dana J
4995 BRADENTON AVE, SUITE 240
DUBLIN
OH
43017
true
false
false
false
0
Common Stock
2023-07-11
4
A
0
250000
0
A
250000
D
Shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan.
/s/ Gioia Gentile for Dana J. Moss, by power of attorney
2023-07-17